Troels T. Andreassen

Systemic intermittent parathyroid hormone treatment improves osseointegration of press-fit inserted implants in cancellous bone

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  • Henrik Daugaard, Denmark
  • Brian Elmengaard
  • Troels Torp Andreassen
  • Anders Lamberg, Denmark
  • Joan E Bechtold, Orthopaedic Biomechanics Laboratory, Midwest Research Foundation, Minneapolis, MN, United States
  • Kjeld Soballe, Denmark
Intermittent administration of parathyroid hormone (PTH) has an anabolic effect on bone, as confirmed in human osteoporosis studies, distraction osteogenesis, and fracture healing. PTH in rat models leads to improved fixation of implants in low-density bone or screw insertion transcortically.
Original languageEnglish
JournalActa Orthopaedica (Print Edition)
Pages (from-to)411-9
Number of pages9
Publication statusPublished - 2012

    Research areas

  • Alloys, Animals, Biomechanics, Coated Materials, Biocompatible, Disease Models, Animal, Dogs, Drug Administration Schedule, Humans, Injections, Subcutaneous, Male, Osseointegration, Parathyroid Hormone, Photomicrography, Prostheses and Implants, Prosthesis Design, Prosthesis Implantation, Random Allocation, Reference Values, Shear Strength, Tibia, Titanium, Treatment Outcome

See relations at Aarhus University Citationformats

ID: 52811814